RASA1 (NM_002890) Human Mass Spec Standard

CAT#: PH305473

RASA1 MS Standard C13 and N15-labeled recombinant protein (NP_002881)


  View other "RASA1" proteins (3)

USD 3,255.00

In Stock*

Size
    • 10 ug

Product Images

Frequently bought together (2)
Transient overexpression lysate of RAS p21 protein activator (GTPase activating protein) 1 (RASA1), transcript variant 1
    • 100 ug

USD 436.00


RASA1 (GAP ) mouse monoclonal antibody, clone OTI1H2 (formerly 1H2)
    • 100 ul

USD 447.00

Other products for "RASA1"

Specifications

Product Data
Tag C-Myc/DDK
Species Human
Expression Host HEK293
Expression cDNA Clone or AA Sequence RC205473
Predicted MW 116.4 kDa
Protein Sequence
Purity > 80% as determined by SDS-PAGE and Coomassie blue staining
Concentration >0.05 µg/µL as determined by microplate BCA method
Labeling Method Labeled with [U- 13C6, 15N4]-L-Arginine and [U- 13C6, 15N2]-L-Lysine
Buffer 25 mM Tris-HCl, 100 mM glycine, pH 7.3
Storage Store at -80°C. Avoid repeated freeze-thaw cycles.
Stability Stable for 3 months from receipt of products under proper storage and handling conditions.
Reference Data
RefSeq NP_002881
RefSeq Size 4402
RefSeq ORF 3141
Synonyms CM-AVM; CMAVM; CMAVM1; GAP; p120; p120GAP; p120RASGAP; PKWS; RASA; RASGAP
Locus ID 5921
UniProt ID P20936, Q59GK3
Cytogenetics 5q14.3
Summary The protein encoded by this gene is located in the cytoplasm and is part of the GAP1 family of GTPase-activating proteins. The gene product stimulates the GTPase activity of normal RAS p21 but not its oncogenic counterpart. Acting as a suppressor of RAS function, the protein enhances the weak intrinsic GTPase activity of RAS proteins resulting in the inactive GDP-bound form of RAS, thereby allowing control of cellular proliferation and differentiation. Mutations leading to changes in the binding sites of either protein are associated with basal cell carcinomas. Mutations also have been associated with hereditary capillary malformations (CM) with or without arteriovenous malformations (AVM) and Parkes Weber syndrome. Alternative splicing results in two isoforms where the shorter isoform, lacking the N-terminal hydrophobic region but retaining the same activity, appears to be abundantly expressed in placental but not adult tissues. [provided by RefSeq, May 2012]
Protein Families Druggable Genome
Protein Pathways Axon guidance, MAPK signaling pathway

Documents

Other Versions

{0} Product Review(s)

0 Product Review(s) Submit review

Be the first one to submit a review

Product Citations

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.